Clinical Trial Update: Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea. [NA]

View source ↗

Summary

A completed trial comparing UVA-1 phototherapy (medium/high dose, 3x/week) against fluocinonide 0.05% cream for symmetric limited morphea.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Localized Scleroderma

Drugs mentioned

• Fluocinonide 0.05% Cream (fluocinonide)
• UVA-1 phototherapy (medium/high dose)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Symmetric Limited Morphea | NA | Status: COMPLETED